Article

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses

2021-12-23

Abstract excerpt

<h4>SUMMARY</h4> Continuous emergence of SARS-CoV-2 variants of concern (VOC) is fueling the COVID-19 pandemic. Omicron (B.1.1.529), is rapidly spreading worldwide. The large number of mutations in its Spike raised concerns about a major antigenic drift that could significantly decrease vaccine efficacy and infection-induced immunity. A long interval between BNT162b2 mRNA doses was shown to elicit antibodies that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8df9783c-4d1a-512b-8770-383572fc584a
DOI: 10.1101/2021.12.21.473679

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between dosesDOI 10.1101/2021.12.21.473679Read

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.Semantic proximity Read

SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against OmicronSemantic proximity Read

Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccinesSemantic proximity Read

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemicSemantic proximity Read

mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron VariantSemantic proximity Read

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity Read

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individualsSemantic proximity Read

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathwaySemantic proximity Read

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune responseSemantic proximity Read

Plasma neutralization properties of the SARS-CoV-2 Omicron variantSemantic proximity Read

Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac VaccinationSemantic proximity Read

Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipientsSemantic proximity Read